Weight-loss jabs could halve sickness absence and ease strain on NHS, study suggests | Weight-loss drugs
The widespread adoption of GLP-1 receptor agonists—the class of weight-loss jabs including Wegovy and Ozempic—could do more than just reduce waistlines; it may fundamentally alleviate the … Read more